|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4704 | |
| A61K 31/221 | |||
| A61K 31/255 | |||
| A61K 31/445 | |||
| A61K 31/473 | |||
| A61P 43/00 |
| (11) | Number of the document | 1853265 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06733984.6 |
| Date of filing the European patent application | 2006-01-27 | |
| (97) | Date of publication of the European application | 2007-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/002977 |
| Date | 2006-01-27 |
| (87) | Number | WO 2006/081444 |
| Date | 2006-08-03 |
| (30) | Number | Date | Country code |
| 648307 P | 2005-01-28 | US | |
| 707192 P | 2005-08-09 | US |
| (72) |
GORDON, Leslie, B., US
COLLINS, Francis, S., US
GLOVER, Thomas, US
GLYNN, Michael, W., US
CAPELL, Brian, C., US
COX, Adrienne, D., c/o Dept. Radiation Oncology, US
DER, Channing, J., c/o Lineberger Comp.Cancer Ctr., US
|
| (73) |
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL,
Office of Technology Development, Campus Box 4105, 308 Bynum Hall, Chapel Hill, NC 27599-4105,
US
The Government of the United States of America as represented by the Secretary of the Department of Health and Human S, National Institutes of Health, Suite 325, 6011 Executive Boulevard, Rockville, MD 20852-3804, US The Progeria Research Foundation, Inc., P.O. Box 3453, Peabody, MA 01961-3453, US THE REGENTS OF THE UNIVERSITY OF MICHIGAN, Wolverine Tower Room 2071, 3003 South State Street, Ann Arbor, Michigan 48109-1290, US |
| (54) | FARNESYLTRANSFERASE INHIBITORS FOR USE IN THE TREATMENT OF LAMINOPATHIES, CELLULAR AGING AND ATHEROSCLEROSIS |
| FARNESYLTRANSFERASE INHIBITORS FOR USE IN THE TREATMENT OF LAMINOPATHIES, CELLULAR AGING AND ATHEROSCLEROSIS |